Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HiPPI: A Phase 2 Trial of Hypofractionated Pencil Beam Scanning Proton Therapy for Benign Intracranial Tumors

NCT04278118 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT04278118
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04278118 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HiPPI: A Phase 2 Trial of Hypofractionated Pencil Beam Scanning Proton Therapy for Benign Intracranial Tumors
Lead sponsor
Emory University
Phase
Not applicable
Overall status
Recruiting
Start date
February 18, 2020
Completion date
December 1, 2031
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

grade i meningioma, grade ii meningioma, grade iii meningioma, intracranial neoplasm, nerve sheath neoplasm, pituitary gland adenoma, schwannoma